Inhibition of the renin-angiotensin system (RAS) has been shown to decrease mortality and morbidity in patients with heart failure and postmyocardial infarction. Experimental and clinical data ...

The finding could open the door to better ways to manage high blood pressure and other vascular diseases. The class of drugs, known as renin–angiotensin system (RAS) inhibitors, block the effects of ...

The class of drugs, known as renin–angiotensin system (RAS) inhibitors, block the effects of the renin enzyme, relaxing blood vessels and allowing blood to flow more easily. They are widely used ...

A new study by researchers at the University of Virginia (UVA) School of Medicine has uncovered how prolonged use of renin-angiotensin system (RAS) inhibitors – commonly prescribed for high blood ...

The renin-angiotensin system (RAS) plays a crucial role in regulating blood pressure. Renin is a hormone enzyme that is produced by cells in the kidney which are stimulated when blood pressure drops.

Commonly prescribed drugs used to treat high blood pressure have been shown to, over time, wreck the kidneys' ability to ...

Now that they know the cause, researchers say the next step is to figure out how to use the effective blood pressure drugs known as renin-angiotensin system inhibitors—often called RAS ...

Drugs known as renin-angiotensin system inhibitors help lower blood ... better ways to detect the early stages of kidney disease RAS inhibitors remain safe to take.

The commonly prescribed drugs are known as renin-angiotensin system, or RAS, inhibitors. They block the effects of the renin enzyme, allowing blood vessels to relax and blood to flow more easily.

Now that they know the cause, researchers say the next step is to figure out how to use the effective blood pressure drugs known as renin-angiotensin system inhibitors – often called RAS inhibitors – ...

Going to dances in his hometown of Central Village, St Catherine was a favourite pastime for Ras Emmanuel during the 1980s and 1990s. It inspired him to become a professional entertainer ...

Patients who received GLP-1 RAs were compared to those who received dipeptidyl peptidase-4 (DPP-4) inhibitors; after propensity score matching, the final analysis included two cohorts of 168,428 ...